Your browser is no longer supported. Please, upgrade your browser.
BCR [NYSE]
CR Bard Inc.
IndexS&P 500 P/E45.29 EPS (ttm)3.76 Insider Own0.60% Shs Outstand74.26M Perf Week-0.39%
Market Cap12.64B Forward P/E17.10 EPS next Y9.96 Insider Trans-53.28% Shs Float73.41M Perf Month-1.32%
Income289.70M PEG4.00 EPS next Q2.07 Inst Own91.50% Short Float3.29% Perf Quarter-0.29%
Sales3.32B P/S3.80 EPS this Y-55.20% Inst Trans-0.58% Short Ratio4.12 Perf Half Y14.27%
Book/sh23.97 P/B7.10 EPS next Y10.46% ROA5.70% Target Price177.62 Perf Year18.84%
Cash/sh12.93 P/C13.17 EPS next 5Y11.32% ROE15.70% 52W Range132.04 - 180.35 Perf YTD2.33%
Dividend0.88 P/FCF27.86 EPS past 5Y-4.00% ROI10.10% 52W High-5.58% Beta0.71
Dividend %0.52% Quick Ratio2.70 Sales past 5Y5.60% Gross Margin62.10% 52W Low28.96% ATR3.05
Employees13900 Current Ratio3.30 Sales Q/Q9.60% Oper. Margin24.40% RSI (14)47.82 Volatility1.73% 1.59%
OptionableYes Debt/Eq0.82 EPS Q/Q-79.20% Profit Margin8.70% Rel Volume0.94 Prev Close167.66
ShortableYes LT Debt/Eq0.78 EarningsJan 29 AMC Payout22.30% Avg Volume586.05K Price170.28
Recom2.90 SMA20-1.37% SMA50-1.17% SMA2008.71% Volume552,100 Change1.56%
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Jun-04-13Reiterated Deutsche Bank Hold $98 → $106
Mar-08-13Reiterated Northland Capital Market Perform $105 → $111
Feb-01-13Reiterated Barclays Overweight $117 → $112
Feb-01-13Initiated Mizuho Neutral $88 → $94
Jan-04-13Reiterated Deutsche Bank Hold $93 → $97
Nov-20-12Initiated Stifel Nicolaus Hold
Oct-24-12Reiterated Mizuho Neutral $93 → $88
Sep-24-12Upgrade Barclays Underweight → Overweight $101 → $117
Apr-25-12Reiterated Mizuho Neutral $86 → $93
Feb-23-12Initiated Northland Securities Market Perform $105
Sep-23-11Reiterated Barclays Capital Underweight $82 → $87
Sep-16-11Initiated Rodman & Renshaw Mkt Perform
Feb-01-11Downgrade Morgan Joseph Buy → Hold
Mar-04-15 12:00PM  Bard to Present at Barclays Global Healthcare Conference Business Wire
Feb-25-15 01:04PM  BARD C R INC /NJ/ Financials EDGAR Online Financials
10:30AM  Bard to Present at Raymond James Institutional Investors Conference Business Wire
Feb-24-15 04:49PM  Reversing a Declining Pattern in Earnings Per Share Gurufocus
Feb-23-15 06:14PM  CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog Zacks
Feb-19-15 11:52AM  CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient Use Business Wire
Feb-18-15 02:12PM  BARD C R INC /NJ/ Files SEC form 10-K, Annual Report EDGAR Online
10:03AM  CryoLife (CRY) Down as Q4 Earnings Fall; Revenues Rise Y/Y - Analyst Blog Zacks
Feb-13-15 02:06PM  C.R. Bard, Inc. -- Moody's downgrades C.R. Bard's long term rating to Baa1 from A3; outlook stable at Moody's
Feb-11-15 07:54AM  JMP Securities Covers Mostly Good News From Pharma Pending More Visibility Benzinga
Feb-10-15 05:40PM  CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog Zacks
Feb-09-15 09:00AM  Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix┬« Drug Coated Balloon PR Newswire
Feb-03-15 07:28PM  Lightning Round: Chicken is now a commodity at CNBC
Jan-30-15 05:51PM  Friday's Market Recap Yahoo Finance Contributors
03:00PM  C.R. Bard Beats Q4 Earnings and Sales, 15' Outlook Cautious - Analyst Blog Zacks
Jan-29-15 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:12PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:05PM  Bard Announces Fourth Quarter Results Business Wire
07:07AM  Q4 2014 C R Bard Inc Earnings Release - After Market Close CCBN
Jan-28-15 03:30PM  Zimmer (ZMH) Likely to Miss Estimates this Earnings Season - Analyst Blog Zacks
01:40PM  Is Thermo Fisher (TMO) Poised to Surprise Q4 Earnings? - Analyst Blog Zacks
Jan-27-15 02:40PM  Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst Blog Zacks
10:30AM  Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
Jan-26-15 12:10PM  CareFusion Banks on Pipeline Strength, Pricing Woes Remain - Analyst Blog Zacks
Jan-23-15 02:00PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
Jan-20-15 02:30PM  Henry Schein to Expand in Animal Health with scil Acquisition - Analyst Blog Zacks
Jan-15-15 06:20PM  Teleflex Collaborates with HealthTrust for ARROW Devices - Analyst Blog Zacks
06:05PM  Henry Schein Expands Dental Practice Transition in Florida - Analyst Blog Zacks
Jan-13-15 05:00PM  BARD C R INC /NJ/ Files SEC form 8-K, Other Events EDGAR Online
Jan-12-15 05:29PM  And Oil continues to fall... Yahoo Finance Contributors
Jan-06-15 12:00PM  Bard to Host Earnings Conference Call on January 29, 2015 Business Wire
11:00AM  Bard to Present at J.P. Morgan Healthcare Conference Business Wire
08:02AM  Top-Performing Core Funds Make Up Some Ground at Investor's Business Daily
Jan-05-15 03:57PM  Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades Benzinga
Dec-29-14 12:48PM  [$$] St. Jude's Six-Week Surge About to Start at Barrons.com
Dec-12-14 12:01AM  Bard Judge Says Implant Maker Facing Billions in Verdicts at Bloomberg
Dec-10-14 07:55PM  Top Performing Funds: Core Style Straddles The Line at Investor's Business Daily
04:05PM  Bard Declares Quarterly Dividend Business Wire
10:04AM  12 'financial potholes' to avoid now at USA TODAY
Dec-05-14 03:09PM  The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y Zacks
Dec-03-14 07:55PM  Top Performing Funds: Core Style Straddles The Line at Investor's Business Daily
04:50PM  Teleflex Partners with Premier to Expand Dialysis Portfolio Zacks
Nov-25-14 05:55PM  Henry Schein, Cardinal Health Sign Physician Service Deal Zacks
Nov-21-14 03:27PM  BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance EDGAR Online
Nov-20-14 03:39PM  Invacare (IVC) Down to Strong Sell on Dismal Q3 Results Zacks
03:38PM  Henry Schein Strong on Healthy Track Record, Fundamentals Zacks
Nov-19-14 02:30PM  Bard to Present at the Piper Jaffray Healthcare Conference Business Wire
12:10PM  CR Bard (BCR) Scales 52-Week High on Strong Q3 Results Zacks
Nov-17-14 05:10PM  Covidien's Test Data Positive for VenaSeal Closure System Zacks
03:34PM  LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 Zacks
04:33AM  Cramer: Stocks That Stand Out TheStreet
Nov-13-14 04:17PM  Miami jury begins deliberations in Boston Scientific mesh trial Reuters
Nov-12-14 09:00AM  MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall Zacks
Nov-11-14 01:50PM  Boston Scientific Shows Strength on Core Market Stabilization Zacks
10:30AM  Henry Schein Tops Q3 Earnings, Revenues; Shares Rally Zacks
09:10AM  Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up Zacks
Nov-07-14 08:30AM  CareFusion Q1 Earnings, Revenues Rise and Beat Estimates Zacks
Nov-05-14 01:00PM  Bard to Present at the Stifel Healthcare Conference Business Wire
Nov-04-14 05:07PM  Covidien to Sell Stellarex DCB to Spectranetics for $30M Zacks
Nov-03-14 09:03AM  RPT-Halyard Health poised to shine in debut on back of Ebola scare Reuters
Oct-28-14 09:46AM  Today CR Bard (BCR) Hits New Lifetime High at TheStreet
Oct-23-14 05:02PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report EDGAR Online
08:40AM  CR Bard Beats Q3 Earnings and Revenues, '14 View Raised Zacks
Oct-22-14 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:12PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:05PM  Bard Announces Third Quarter Results Business Wire
07:07AM  Q3 2014 C R Bard Inc Earnings Release - After Market Close CCBN
Oct-15-14 05:36PM  Is CR Bard (BCR) Poised to Beat Earnings This Season? Zacks
Oct-13-14 02:20PM  CR Bard's Lutonix 035: First FDA-Approved DCB in the US Zacks
Oct-10-14 02:52PM  First Drug-Coated Balloon Approved By FDA For Leg Blockages at Forbes
09:27AM  The Lutonix┬« 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease Business Wire
Oct-08-14 04:05PM  Bard Declares Quarterly Dividend Business Wire
Oct-07-14 06:21PM  Bard Said to Pay $21 Million in First Big Vaginal-Mesh Accord at Bloomberg
07:00AM  4 Stocks Spiking on Unusual Volume at TheStreet
Oct-03-14 12:11PM  Damages slashed to $34.6 mln in Boston Scientific mesh trial Reuters
Oct-01-14 11:00AM  Bard to Host Earnings Conference Call on October 22, 2014 Business Wire
Sep-30-14 07:35PM  Endo reaches deal to end remaining U.S. lawsuits over mesh Reuters
Sep-24-14 07:25PM  Small Caps Rule Core Funds Over Long Run at Investor's Business Daily
Sep-17-14 04:35PM  CR Bard Improves on Strong Product Strategy Zacks
Sep-09-14 04:31PM  Boston Scientific ordered to pay $73 million over mesh device Reuters
Sep-07-14 03:49PM  No More a Simple Distributor Gurufocus
Aug-20-14 09:00AM  Medical Device Stocks Report Accesswire
Aug-04-14 10:58AM  5 Rocket Stocks to Buy for Correction Gains at TheStreet
Aug-01-14 11:59AM  Terrance H. Gregg, the CEO of Dexcom, Inc. (DXCM), Interviews with The Wall Street Transcript Wall Street Transcript
Jul-25-14 03:20PM  C R Bard Q2 Earnings and Revenues Beat Estimates Zacks
01:57PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report EDGAR Online
Jul-24-14 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:14PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
04:05PM  Bard Announces Second Quarter Results Business Wire
07:07AM  Q2 2014 C. R. Bard, Inc. Earnings Release - After Market Close CCBN
Jul-14-14 05:51AM  Should You Avoid The 5 Lowest Yielding Dividend Aristocrats? at Seeking Alpha
Jul-10-14 10:38AM  Why Lower-Yielding Stocks Provide Better Long-Term Returns at Seeking Alpha
Jul-01-14 11:00AM  Bard to Host Earnings Conference Call on July 24, 2014 Business Wire
Jun-30-14 01:04PM  3 Stocks Pulling The Health Services Industry Downward at TheStreet
Jun-26-14 04:56AM  A Smart Move for Endo International? at Motley Fool
Jun-18-14 12:24PM  C.R. Bard downgraded by Barclays Briefing.com
10:54AM  Headwinds For C.R. Bard, According To Barclays Benzinga
09:14AM  Will This Analyst Downgrade Hurt C.R. Bard (BCR) Stock Today? at TheStreet
08:16AM  Analysts' Actions: C.R. Bard, Gap, GNC, Medtronic, Tyson Foods TheStreet
Jun-17-14 05:41AM  10 Dividend Increases For Further Review at Seeking Alpha
C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products that include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as other products, such as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRESLAWSKY MARC CDirectorFeb 24Option Exercise76.367,200549,76619,319Feb 26 06:13 PM
BRESLAWSKY MARC CDirectorFeb 24Sale174.377,2001,255,49312,119Feb 26 06:13 PM
RING TIMOTHY MChairman and CEOFeb 23Option Exercise83.4720,0001,669,460141,455Feb 25 07:28 PM
RING TIMOTHY MChairman and CEOFeb 23Sale176.3320,0003,526,583121,455Feb 25 07:28 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Option Exercise96.5111,4401,104,05837,111Feb 24 07:08 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 20Sale176.0316,0912,832,52321,020Feb 24 07:08 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 20Sale174.852,987522,26423,646Feb 24 07:08 PM
Luboff Sharon MGroup Vice PresidentFeb 19Sale174.421,117194,83031,149Feb 20 03:51 PM
WEILAND JOHN HPresident and COOFeb 19Sale174.998,4131,472,21179,409Feb 20 03:51 PM
Beasley Jim CGroup PresidentFeb 19Sale174.792,884504,10424,313Feb 20 03:51 PM
Groetelaars John PGroup Vice PresidentFeb 19Sale175.144,566799,70520,103Feb 20 03:51 PM
RING TIMOTHY MChairman and CEOFeb 18Sale175.454,531794,980121,455Feb 20 03:51 PM
Collins Timothy PGroup PresidentFeb 18Sale175.554,583804,53831,512Feb 20 03:51 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 18Sale175.561,213212,95612,679Feb 20 03:51 PM
HENKEL HERBERT LDirectorFeb 17Option Exercise76.367,200549,76617,561Feb 19 05:29 PM
HENKEL HERBERT LDirectorFeb 17Sale174.607,2001,257,12810,361Feb 19 05:29 PM
WEILAND JOHN HPresident and COOFeb 17Sale174.5113,6162,376,18087,822Feb 18 05:48 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 17Sale174.586,1461,072,95126,633Feb 18 05:48 PM
Beasley Jim CGroup PresidentFeb 17Sale174.589,9041,729,00627,197Feb 18 05:48 PM
Luboff Sharon MGroup Vice PresidentFeb 17Sale174.578,7721,531,29732,266Feb 18 05:48 PM
Collins Timothy PGroup PresidentFeb 17Sale174.572,210385,79540,253Feb 18 05:48 PM
RING TIMOTHY MChairman and CEOFeb 17Sale175.182,453429,721130,097Feb 18 05:48 PM
RING TIMOTHY MChairman and CEOFeb 13Sale174.473,831668,387132,550Feb 18 05:48 PM
WHITE TONY LDirectorFeb 12Option Exercise65.112,400156,27015,268Feb 17 02:18 PM
RING TIMOTHY MChairman and CEOFeb 12Sale173.7414,3632,495,434138,758Feb 13 08:08 PM
Collins Timothy PGroup PresidentFeb 12Sale174.006,5641,142,15043,408Feb 13 08:08 PM
Christian Patricia GVP -Quality, Reg & Med AffairsFeb 12Sale173.971,408244,95214,489Feb 13 08:08 PM
WHITE TONY LDirectorFeb 12Sale174.172,400418,01412,868Feb 17 02:18 PM
WELTERS ANTHONYDirectorFeb 09Sale169.021,563264,1771,956Feb 11 03:28 PM
Luboff Sharon MGroup Vice PresidentFeb 03Sale170.2139667,40329,218Feb 05 03:31 PM
RING TIMOTHY MChairman and CEOJan 22Option Exercise83.4720,0001,669,460141,448Jan 23 05:31 PM
RING TIMOTHY MChairman and CEOJan 22Sale177.8420,0003,556,780121,448Jan 23 05:31 PM
RING TIMOTHY MChairman and CEODec 22Option Exercise79.8632,3252,581,387153,773Dec 23 12:47 PM
RING TIMOTHY MChairman and CEODec 22Sale169.6432,3255,483,533121,448Dec 23 12:47 PM
Beasley Jim CGroup PresidentDec 17Sale168.424,525762,09923,100Dec 18 04:17 PM
Luboff Sharon MGroup Vice PresidentDec 17Sale168.363,564600,04129,738Dec 18 04:17 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 17Sale168.0232855,11212,196Dec 18 04:17 PM
Collins Timothy PGroup PresidentDec 17Sale168.413,960666,91733,261Dec 18 04:17 PM
Beasley Jim CGroup PresidentDec 16Option Exercise89.9314,6341,316,04242,259Dec 17 06:15 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Option Exercise84.585,626475,81930,498Dec 17 06:15 PM
Beasley Jim CGroup PresidentDec 16Sale167.4714,6342,450,73927,625Dec 17 06:15 PM
RING TIMOTHY MChairman and CEODec 16Sale166.6015,2322,537,668121,448Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 16Sale167.019,5041,587,23383,486Dec 17 06:15 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 16Sale167.475,626942,19224,872Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 15Option Exercise84.5813,5891,149,290115,785Dec 17 06:15 PM
WEILAND JOHN HPresident and COODec 15Sale166.5613,5892,263,342102,196Dec 17 06:15 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 12Sale168.3016026,92812,708Dec 16 03:59 PM
Christian Patricia GVP -Quality, Reg & Med AffairsDec 10Sale169.201,269214,71413,161Dec 12 05:37 PM
RING TIMOTHY MChairman and CEODec 09Sale170.209,5501,625,373151,433Dec 10 04:07 PM
WEILAND JOHN HPresident and COODec 09Sale170.326,3501,081,508102,196Dec 10 04:07 PM
RING TIMOTHY MChairman and CEONov 21Option Exercise77.1560,0004,629,060230,233Nov 25 05:16 PM
RING TIMOTHY MChairman and CEONov 21Sale166.7560,00010,005,125170,233Nov 25 05:16 PM
Lupisella Frank JrVice President and ControllerOct 30Option Exercise85.695,980512,42924,161Nov 03 05:03 PM
Lupisella Frank JrVice President and ControllerOct 30Sale160.205,980957,99618,181Nov 03 05:03 PM
RING TIMOTHY MChairman and CEOOct 22Option Exercise77.1560,0004,629,060230,233Oct 24 04:08 PM
RING TIMOTHY MChairman and CEOOct 22Sale149.0760,0008,944,243170,233Oct 24 04:08 PM
RING TIMOTHY MChairman and CEOOct 06Option Exercise77.1560,0004,629,060230,233Oct 08 04:55 PM
RING TIMOTHY MChairman and CEOOct 06Sale148.0060,0008,880,000170,233Oct 08 04:55 PM
WEILAND JOHN HPresident and COOSep 10Option Exercise84.5827,1792,298,664141,875Sep 11 04:22 PM
WEILAND JOHN HPresident and COOSep 10Sale149.5027,1794,063,261114,696Sep 11 04:22 PM
RING TIMOTHY MChairman and CEOSep 02Option Exercise66.8010,228683,179180,461Sep 04 02:13 PM
RING TIMOTHY MChairman and CEOSep 02Sale148.8310,2281,522,188170,233Sep 04 02:13 PM
KELLY BRONWEN KVP - Human ResourcesAug 04Option Exercise83.4710,055839,32131,910Aug 06 03:34 PM
KELLY BRONWEN KVP - Human ResourcesAug 04Sale150.2510,0551,510,73721,855Aug 06 03:34 PM
RING TIMOTHY MChairman and CEOAug 01Option Exercise66.8010,231683,380180,464Aug 05 05:11 PM
RING TIMOTHY MChairman and CEOAug 01Sale149.0410,2311,524,808170,233Aug 05 05:11 PM
Melcher David FDirectorJul 31Buy150.4950075,243500Aug 01 03:33 PM
Collins Timothy PGroup PresidentJul 30Option Exercise86.1529,9402,579,18171,971Aug 01 03:33 PM
Collins Timothy PGroup PresidentJul 30Sale150.3830,9144,648,88841,057Aug 01 03:33 PM
Christian Patricia GVP -Quality, Reg & Med AffairsJul 29Option Exercise85.7312,7011,088,86327,498Jul 31 05:23 PM
Luboff Sharon MGroup Vice PresidentJul 29Option Exercise88.765,115453,98242,251Jul 31 05:23 PM
Luboff Sharon MGroup Vice PresidentJul 29Sale151.375,115774,23637,136Jul 31 05:23 PM
Christian Patricia GVP -Quality, Reg & Med AffairsJul 29Sale151.3412,7011,922,21614,797Jul 31 05:23 PM
RING TIMOTHY MChairman and CEOJul 01Option Exercise66.8010,231683,380182,447Jul 02 02:04 PM
RING TIMOTHY MChairman and CEOJul 01Sale144.3010,2311,476,318172,216Jul 02 02:04 PM
RING TIMOTHY MChairman and CEOJun 02Option Exercise66.8010,231683,380182,447Jun 04 05:12 PM
RING TIMOTHY MChairman and CEOJun 02Sale147.5010,2311,509,069172,216Jun 04 05:12 PM
RING TIMOTHY MChairman and CEOMay 01Option Exercise66.8010,231683,380182,447May 05 04:38 PM
RING TIMOTHY MChairman and CEOMay 01Sale137.2010,2311,403,650172,216May 05 04:38 PM
RING TIMOTHY MChairman and CEOApr 01Option Exercise66.8010,231683,380182,447Apr 03 07:18 PM
RING TIMOTHY MChairman and CEOApr 01Sale149.2210,2311,526,666172,216Apr 03 07:18 PM